The emerging use of immune checkpoint blockade in the adjuvant setting for solid tumors: a review
E Moujaess, FG Haddad, R Eid, HR Kourie - Immunotherapy, 2019 - Taylor & Francis
E Moujaess, FG Haddad, R Eid, HR Kourie
Immunotherapy, 2019•Taylor & FrancisThe use of immune checkpoint inhibitors has been approved in the advanced and metastatic
setting for many types of solid tumors. Nonetheless, their role in the adjuvant setting is
limited to the treatment of surgically resected melanoma. Ipilimumab was the first immune
checkpoint inhibitor approved for this indication, followed by nivolumab and pembrolizumab.
Many ongoing trials are evaluating these molecules in the postoperative setting, alone or in
combination with other therapies. Preliminary results are promising regarding the treatment …
setting for many types of solid tumors. Nonetheless, their role in the adjuvant setting is
limited to the treatment of surgically resected melanoma. Ipilimumab was the first immune
checkpoint inhibitor approved for this indication, followed by nivolumab and pembrolizumab.
Many ongoing trials are evaluating these molecules in the postoperative setting, alone or in
combination with other therapies. Preliminary results are promising regarding the treatment …
The use of immune checkpoint inhibitors has been approved in the advanced and metastatic setting for many types of solid tumors. Nonetheless, their role in the adjuvant setting is limited to the treatment of surgically resected melanoma. Ipilimumab was the first immune checkpoint inhibitor approved for this indication, followed by nivolumab and pembrolizumab. Many ongoing trials are evaluating these molecules in the postoperative setting, alone or in combination with other therapies. Preliminary results are promising regarding the treatment of other cutaneous tumors, lung cancers, head and neck squamous cell carcinomas, bladder cancer and renal cell carcinomas. Some data assessing their use for the adjuvant treatment of esophageal, colorectal, ovarian cancer and other solid tumors are similarly emerging.
![](/scholar/images/qa_favicons/tandfonline.com.png)
以上显示的是最相近的搜索结果。 查看全部搜索结果